Common use of Government Acts Clause in Contracts

Government Acts. In the event that any act, regulation, directive, or law of a country or its government, including its departments, agencies or courts, should make impossible or prohibit, restrain, modify or limit any material act or obligation of CFFT or Vertex under this Agreement, the party, if any, not so affected, shall have the right, at its option, to suspend or terminate this Agreement as to such country, if good faith negotiations between the parties to make such modifications therein as may be necessary to fairly address the impact thereof, are not successful after a reasonable period of time in producing mutually acceptable modifications to this Agreement.

Appears in 8 contracts

Samples: Research, Development and Commercialization Agreement (Vertex Pharmaceuticals Inc / Ma), Research, Development and Commercialization Agreement (Royalty Pharma PLC), Research, Development and Commercialization Agreement (Royalty Pharma PLC)

AutoNDA by SimpleDocs

Government Acts. In the event that any act, regulation, directive, or law of a country or its government, including its departments, agencies or courts, should make impossible or prohibit, restrain, modify or limit any material act or obligation of CFFT Auxilium or Vertex BTC under this Agreement, the partyParty, if any, not so affected, affected shall have the right, at its option, to suspend or terminate this Agreement as to such country, if good faith negotiations between the parties Parties to make such modifications therein to this Agreement as may be necessary to fairly address the impact thereof, are not successful after a reasonable period of time are not successful in producing mutually acceptable modifications to this Agreement.

Appears in 7 contracts

Samples: Development, Commercialization and Supply Agreement (Auxilium Pharmaceuticals Inc), Development and License Agreement (Auxilium Pharmaceuticals Inc), Development, Commercialization and Supply Agreement (Auxilium Pharmaceuticals Inc)

Government Acts. In the event that any act, regulation, directive, or law of a country or its government, including its departments, agencies or courts, should make impossible or prohibit, restrain, modify or limit any material act or obligation of CFFT or Vertex the Parties under this Agreement, the partyParty, if any, not so affected, shall have the right, at its option, to suspend or terminate this Agreement as to such country, if good faith negotiations between the parties Parties to make such modifications therein as may be necessary to fairly address the impact thereof, are not successful after a reasonable period of time in producing mutually acceptable modifications to this Agreement.

Appears in 4 contracts

Samples: Collaboration and Option Agreement, Collaboration and Option Agreement (Discovery Partners International Inc), Collaboration and Option Agreement (Infinity Pharmaceuticals, Inc.)

Government Acts. In the event that any act, regulation, directive, or law of a country or its government, including its departments, agencies or courts, should make impossible or prohibit, restrain, modify or limit any material act or obligation of CFFT MITSUBISHI or Vertex VERTEX under this Agreement, the partyParty, if any, not so affected, shall have the right, at its option, to suspend or terminate this Agreement as to such country, if good faith negotiations between the parties Parties to make such modifications therein as may be necessary to fairly address the impact thereof, thereof are not successful after a reasonable period of time in producing mutually acceptable modifications to this Agreement.

Appears in 3 contracts

Samples: License, Development and Commercialization Agreement (Vertex Pharmaceuticals Inc / Ma), License, Development and Commercialization Agreement (Vertex Pharmaceuticals Inc / Ma), License, Development and Commercialization Agreement (Vertex Pharmaceuticals Inc / Ma)

Government Acts. In the event that any act, regulation, directive, or law of a country or its government, including its departments, agencies or courts, should make impossible or prohibit, restrain, modify or limit any material act or obligation of CFFT NIBRI or Vertex Myogen under this Agreement, the party, if any, not so affected, shall have the right, at its option, to suspend or terminate this Agreement as to such country, if good faith negotiations between the parties to make such modifications therein as may be necessary to fairly address the impact thereof, are not successful after a reasonable period of time in producing mutually acceptable modifications to this Agreement.

Appears in 3 contracts

Samples: Collaboration and Option Agreement (Myogen Inc), Collaboration and Option Agreement (Myogen Inc), Collaboration and Option Agreement (Myogen Inc)

Government Acts. In the event that any act, regulation, directive, or law of a country or its government, including its departments, agencies or courts, should make impossible or prohibit, restrain, modify or limit any material act or obligation of CFFT Vanda or Vertex Novartis or Novartis AG under this Agreement, the partyParty, if any, not so affected, affected shall have the right, at its option, to suspend or terminate this Agreement as to such country, if good faith negotiations between the parties Parties to make such modifications therein to this Agreement as may be necessary to fairly address the impact thereof, are not successful after a reasonable period of time are not successful in producing mutually acceptable modifications to this Agreement.

Appears in 2 contracts

Samples: License Agreement (Vanda Pharmaceuticals Inc.), License Agreement (Vanda Pharmaceuticals Inc.)

Government Acts. In the event that any act, regulation, directive, or law of a country or its government, including its departments, agencies or courts, should make impossible or prohibit, restrain, modify or limit any material act or obligation of CFFT NOVARTIS or Vertex VERTEX under this Agreement, the party, if any, not so affected, affected shall have the right, at its option, to suspend or terminate this Agreement as to such country, if good faith negotiations between the parties to make such modifications therein to this Agreement as may be necessary to fairly address the impact thereof, are not successful after a reasonable period of time in producing mutually acceptable modifications to this Agreement.

Appears in 2 contracts

Samples: Research and Early Development Agreement (Vertex Pharmaceuticals Inc / Ma), Research and Early Development Agreement (Vertex Pharmaceuticals Inc / Ma)

Government Acts. In the event that any act, regulation, directive, or law of a country or its government, including its departments, agencies or courts, should make impossible or prohibit, restrain, modify or limit any material act or obligation of CFFT SCHERING or Vertex VERTEX under this Agreement, the party, if any, not so affected, shall have the right, at its option, to suspend or terminate this Agreement as to such country, if good faith negotiations between the parties to make such modifications therein as may be necessary to fairly address the impact thereof, are not successful after a reasonable period of time are not successful in producing mutually acceptable modifications to this Agreement.

Appears in 1 contract

Samples: Research Agreement (Vertex Pharmaceuticals Inc / Ma)

Government Acts. In the event that any act, regulation, directive, or law of a country or its government, including its departments, agencies or courts, should make impossible or prohibit, restrain, modify or limit any material act or obligation of CFFT Novartis, Evotec or Vertex any of their respective Affiliates under this Agreement, the partyParty not so affected, if any, not so affected, shall have the right, at its option, to suspend or terminate this Agreement as to such country, if good faith negotiations between the parties Parties to make such modifications therein to this Agreement as may be necessary to fairly address the impact thereof, thereof are not successful after a reasonable period of time in producing mutually acceptable modifications to this Agreement.

Appears in 1 contract

Samples: Research and Collaboration Agreement (Evotec AG)

Government Acts. In the event that any act, regulation, directive, or law of a country or its government, including its departments, agencies or courts, should make impossible or prohibit, restrain, modify or limit any material act or obligation of CFFT HMR or Vertex VERTEX under this Agreement, the party, if any, not so affected, affected shall have the right, at its option, to suspend or terminate this Agreement as to such country, if good faith negotiations between the parties to make such modifications therein to this Agreement as may be necessary to fairly address the impact thereof, are not successful after a reasonable period of time are not successful in producing mutually acceptable modifications to this Agreement.

Appears in 1 contract

Samples: License, Development and Commercialization Agreement (Vertex Pharmaceuticals Inc / Ma)

Government Acts. In the event that any act, regulation, directive, or law of a country or its governmentgovernment within the Territory, including its departments, agencies or courts, should make impossible or prohibit, restrain, modify or limit any material act or obligation of CFFT Taisho or Vertex under this Agreement, the party, if any, not so affected, shall have the right, at its option, to suspend or terminate this Agreement as to such country, if good faith negotiations between the parties to make such modifications therein herein as may be necessary to fairly address the impact thereof, are not successful after a reasonable period of time are not successful in producing mutually acceptable modifications to this Agreement.

Appears in 1 contract

Samples: Collaboration and Option Agreement (Vertex Pharmaceuticals Inc / Ma)

Government Acts. In the event that any act, regulation, directive, or law of a country or its government, including its departments, agencies or courts, should make impossible or prohibit, restrain, modify or limit any material act or obligation of CFFT Avalon or Vertex under this Agreement, the partyParty, if any, not so affected, affected shall have the right, at its option, to suspend or terminate this Agreement as to such country, if good faith negotiations between the parties Parties to make such modifications therein to this Agreement as may be necessary to fairly address the impact thereof, are not successful after a reasonable period of time in producing mutually acceptable modifications to this Agreement.

Appears in 1 contract

Samples: License Agreement (Avalon Pharmaceuticals Inc)

AutoNDA by SimpleDocs

Government Acts. In the event that any act, regulation, directive, or law of a country or its government, including its departments, agencies or courts, should make impossible or prohibit, restrain, modify or limit any material act or obligation of CFFT a Party or Vertex any of its respective Affiliates under this Agreement, the partyParty not so affected, if any, not so affected, shall have the right, at its option, to suspend or terminate this Agreement as to such country, if good faith negotiations between the parties Parties to make such modifications therein to this Agreement as may be necessary to fairly address the impact thereof, thereof are not successful after a reasonable period of time in producing mutually acceptable modifications to this Agreement.

Appears in 1 contract

Samples: Research Collaboration and License Agreement (Combinatorx, Inc)

Government Acts. In the event that any act, regulation, directive, or law of a country or its government, including its departments, agencies or courts, should make impossible or prohibit, restrain, modify or limit any material act or obligation of CFFT SCHERING or Vertex VERTEX under this Agreement, the party, if any, not so affected, affected shall have the right, at its option, to suspend or terminate this Agreement as to such country, if good faith negotiations between the parties to make such modifications therein to this Agreement as may be necessary to fairly address the impact thereof, are not successful after a reasonable period of time are not successful in producing mutually acceptable modifications to this Agreement.

Appears in 1 contract

Samples: Research Agreement (Vertex Pharmaceuticals Inc / Ma)

Government Acts. In the event that any act, regulation, directive, or law of a country or its government, including its departments, agencies or courts, should make impossible or prohibit, restrain, modify or limit any material act or obligation of CFFT SERONO or Vertex VERTEX under this Agreement, the party, if any, not so affected, shall have the right, at its option, to suspend or terminate this Agreement as to such country, if good faith negotiations between the parties to make such modifications therein as may be necessary to fairly address the impact thereof, thereof are not successful after a reasonable period of time in producing mutually acceptable modifications to this Agreement.

Appears in 1 contract

Samples: Research Agreement (Vertex Pharmaceuticals Inc / Ma)

Government Acts. In the event that any act, regulation, directive, or law of a country or its government, including its departments, agencies or courts, should make impossible or prohibit, restrain, modify or limit any material act or obligation of CFFT NOVARTIS or Vertex VERTEX under this Agreement, the party, if any, not so affected, shall have the right, at its option, to suspend or terminate this Agreement as to such country, if good faith negotiations between the parties to make such modifications therein as may be necessary to fairly address the impact thereof, are not successful after a reasonable period of time in producing mutually acceptable modifications to this Agreement.

Appears in 1 contract

Samples: Research and Early Development Agreement (Vertex Pharmaceuticals Inc / Ma)

Government Acts. In the event that any act, regulation, directive, or law of a country or its government, including its departments, agencies or courts, should make impossible or prohibit, restrain, modify or limit any material act or obligation of CFFT or Vertex Predix under this Agreement, the party, if any, not so affected, shall have the right, at its option, to suspend or terminate this Agreement as to such country, if good faith negotiations between the parties Parties to make such modifications therein as may be necessary to fairly address the impact thereof, are not successful after a reasonable period of time in producing mutually acceptable modifications to this Agreement.

Appears in 1 contract

Samples: Research, Development and Commercialization Agreement (Predix Pharmaceuticals Holdings Inc)

Government Acts. In the event that any act, regulation, directive, or law of a country or its government, including its departments, agencies or courts, should make impossible or prohibit, restrain, modify or limit any material act or obligation of CFFT MIP or Vertex Novartis under this Agreement, the partyParty, if any, not so affected, affected shall have the right, at its option, to suspend or terminate this Agreement as to such country, if good faith negotiations between the parties Parties to make such modifications therein to this Agreement as may be necessary to fairly address the impact thereof, are not successful after a reasonable period of time are not successful in producing mutually acceptable modifications to this Agreement.

Appears in 1 contract

Samples: License Agreement (Molecular Insight Pharmaceuticals, Inc.)

Government Acts. In the event that any act, regulation, directive, or law of a country or its government, including its departments, agencies or courts, should make impossible or prohibit, restrain, modify or limit any material act or obligation of CFFT or Vertex the Parties under this Agreement, the partyParty, if any, not so affected, shall have the right, at its option, to suspend or terminate this Agreement as to such country, if good faith negotiations negotiat ion s between the parties Parties to make such modifications therein as may be necessary to fairly address the impact thereof, are not successful after a reasonable period of time in producing mutually acceptable modifications to this Agreement.

Appears in 1 contract

Samples: Master Collaboration Agreement (CM Life Sciences II Inc.)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!